IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage

Supplemental Digital Content is available in the text. Background and Purpose— Microglia are among the first cells to respond to intracerebral hemorrhage (ICH), but the mechanisms that underlie their activity following ICH remain unclear. IL (interleukin)-15 is a proinflammatory cytokine that orchestrates homeostasis and the intensity of the immune response following central nervous system inflammatory events. The goal of this study was to investigate the role of IL-15 in ICH injury. Methods— Using brain slices of patients with ICH, we determined the presence and cellular source of IL-15. A transgenic mouse line with targeted expression of IL-15 in astrocytes was generated to determine the role of astrocytic IL-15 in ICH. The expression of IL-15 was controlled by a glial fibrillary acidic protein promoter (GFAP-IL-15tg). ICH was induced by intraparenchymal injection of collagenase or autologous blood. Results— In patients with ICH and wild-type mice subjected to experimental ICH, we found a significant upregulation of IL-15 in astrocytes. In GFAP-IL-15tg mice, we found that astrocyte-targeted expression of IL-15 exacerbated brain edema and neurological deficits following ICH. This aggravated ICH injury in GFAP-IL-15tg mice is accompanied by increased microglial accumulation in close proximity to astrocytes in perihematomal tissues. Additionally, microglial expression of CD86, IL-1β, and TNF-α is markedly increased in GFAP-IL-15tg mice following ICH. Furthermore, depletion of microglia using a colony stimulating factor 1 receptor inhibitor diminishes the exacerbation of ICH injury in GFAP-IL-15tg mice. Conclusions— Our findings identify IL-15 as a mediator of the crosstalk between astrocytes and microglia that exacerbates brain injury following ICH.

[1]  M. Lawton,et al.  Global brain inflammation in stroke , 2019, The Lancet Neurology.

[2]  M. Lawton,et al.  Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Y. Kao,et al.  Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury , 2018, Brain, Behavior, and Immunity.

[4]  F. Shi,et al.  Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice , 2018, Front. Immunol..

[5]  F. Shi,et al.  Depletion of microglia augments the dopaminergic neurotoxicity of MPTP , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  F. Shi,et al.  Stroke-induced immunosuppression and poststroke infection , 2018, Stroke and Vascular Neurology.

[7]  Y. Kong,et al.  Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage , 2018, Stroke.

[8]  F. Shi,et al.  Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Xiaoning Han,et al.  Modulators of microglial activation and polarization after intracerebral haemorrhage , 2017, Nature Reviews Neurology.

[10]  F. Shi,et al.  A TSPO ligand attenuates brain injury after intracerebral hemorrhage , 2017, The FASEB Journal.

[11]  F. Shi,et al.  Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations , 2017, Immunity.

[12]  N. Rothwell,et al.  Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. , 2017, Journal of neurosurgery.

[13]  Minshu Li,et al.  Depletion of microglia exacerbates postischemic inflammation and brain injury , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  F. Shi,et al.  Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity , 2016, Proceedings of the National Academy of Sciences.

[15]  F. Shi,et al.  CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders , 2016, The Journal of Immunology.

[16]  F. Shi,et al.  Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage , 2016, Stroke.

[17]  F. Shi,et al.  Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  F. Shi,et al.  Immune interventions in stroke , 2015, Nature Reviews Neurology.

[19]  B. Khakh,et al.  Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.

[20]  J. Simard,et al.  Targeting secondary injury in intracerebral haemorrhage—perihaematomal oedema , 2015, Nature Reviews Neurology.

[21]  R. Keep,et al.  Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.

[22]  R. Ransohoff,et al.  Innate immunity in the central nervous system. , 2012, The Journal of clinical investigation.

[23]  Jian Wang,et al.  Preclinical and clinical research on inflammation after intracerebral hemorrhage , 2010, Progress in Neurobiology.

[24]  Joseph P. Broderick,et al.  Advances in the management of intracerebral hemorrhage , 2010, Nature Reviews Neurology.

[25]  D. Gomez-Nicola,et al.  Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury , 2008, Glia.

[26]  J. Grotta,et al.  Hematoma resolution as a target for intracerebral hemorrhage treatment: Role for peroxisome proliferator‐activated receptor γ in microglia/macrophages , 2007, Annals of neurology.

[27]  S. Levison,et al.  Neuroinflammation and Both Cytotoxic and Vasogenic Edema Are Reduced in Interleukin-1 Type 1 Receptor-Deficient Mice Conferring Neuroprotection , 2005, Stroke.

[28]  Y. Yoshikai,et al.  Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. , 1998, Gastroenterology.

[29]  I. McInnes,et al.  Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis , 1997, Nature Medicine.

[30]  L. R. Caplan,et al.  Intracerebral haemorrhage , 1992, The Lancet.